Published in Radiat Oncol J on March 27, 2014
Patterns of failure and prognostic factors in resected extrahepatic bile duct cancer: implication for adjuvant radiotherapy. Radiat Oncol J (2014) 0.83
Surgery Alone Versus Surgery Followed by Chemotherapy and Radiotherapy in Resected Extrahepatic Bile Duct Cancer: Treatment Outcome Analysis of 336 Patients. Cancer Res Treat (2015) 0.81
Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat (2013) 7.11
Cholangiocarcinoma. Lancet (2005) 6.01
Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg (1996) 5.42
Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer (2003) 2.96
Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg (1995) 2.28
Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma. Int J Radiat Oncol Biol Phys (2000) 2.21
Surgical management of 552 carcinomas of the extrahepatic bile ducts (gallbladder and periampullary tumors excluded). Results of the French Surgical Association Survey. Ann Surg (1991) 1.75
Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma. World J Surg (2003) 1.62
Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct. Int J Radiat Oncol Biol Phys (2007) 1.31
Treatment strategy for patients with middle and lower third bile duct cancer. Br J Surg (2001) 1.22
Extrahepatic bile duct cancers: surgery alone versus surgery plus postoperative radiation therapy. Int J Radiat Oncol Biol Phys (2009) 1.15
Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone. Ann Surg Oncol (2008) 1.09
Effectiveness of radiation therapy after surgery for hilar cholangiocarcinoma. Surg Today (2005) 1.08
The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection. J Surg Oncol (2009) 1.02
CT analysis of postoperative tumor recurrence patterns in periampullary cancer. Abdom Imaging (2003) 1.01
Predictive factors for prognosis of hilar cholangiocarcinoma: postresection radiotherapy improves survival. Eur J Surg Oncol (2006) 1.01
The role of adjuvant radiotherapy in microscopic tumor control after extrahepatic bile duct cancer surgery. Am J Clin Oncol (2007) 0.97
Role of adjuvant chemoradiotherapy for resected extrahepatic biliary tract cancer. Int J Radiat Oncol Biol Phys (2011) 0.96
Postoperative chemoradiotherapy for extrahepatic bile duct cancer. Int J Radiat Oncol Biol Phys (2010) 0.95
Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience. Am J Clin Oncol (2012) 0.93
Molecular biomarkers in extrahepatic bile duct cancer patients undergoing chemoradiotherapy for gross residual disease after surgery. Radiat Oncol J (2012) 0.84
Impact of adjuvant radiation therapy for microscopic residual tumor after resection of extrahepatic bile duct cancer. Am J Clin Oncol (2013) 0.82
Use of TachoSil(®) patches to prevent pancreatic leaks after distal pancreatectomy: a prospective, multicenter, randomized controlled study. J Hepatobiliary Pancreat Sci (2016) 0.88
Surgery Alone Versus Surgery Followed by Chemotherapy and Radiotherapy in Resected Extrahepatic Bile Duct Cancer: Treatment Outcome Analysis of 336 Patients. Cancer Res Treat (2015) 0.81
Interobserver variability in gross tumor volume delineation for hepatocellular carcinoma : Results of Korean Radiation Oncology Group 1207 study. Strahlenther Onkol (2016) 0.78
Phase I dose escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma. Oncotarget (2016) 0.77
Influencing factors on postoperative hospital stay after laparoscopic cholecystectomy. Korean J Hepatobiliary Pancreat Surg (2016) 0.77
High dose and compartmental target volume may improve patient outcome after radiotherapy for pelvic bone metastases from hepatocellular carcinoma. Oncotarget (2016) 0.77
Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area. Liver Int (2016) 0.77
The role of prophylactic antibiotics on surgical site infection in elective laparoscopic cholecystectomy. Korean J Hepatobiliary Pancreat Surg (2015) 0.75
Multidisciplinary treatment of inferior vena cava leiomyosarcoma. ANZ J Surg (2016) 0.75
The Largest Known Survival Analysis of Patients with Brain Metastasis from Thyroid Cancer Based on Prognostic Groups. PLoS One (2016) 0.75
Duodenum-preserving pancreatic head resection in benign and low-grade malignant pancreatic tumors. Korean J Hepatobiliary Pancreat Surg (2013) 0.75
Validation of group B borderline resectable pancreatic cancer: retrospective analysis. Gut Liver (2014) 0.75
Response to Is radiotherapy the best option for treating hepatocellular carcinoma with PVTT? Liver Int (2017) 0.75
Meeting Highlights: The Second Consensus Conference for Breast Cancer Treatment in Korea. J Breast Cancer (2017) 0.75
Effect of Polyglycolic Acid Mesh for Prevention of Pancreatic Fistula Following Distal Pancreatectomy: A Randomized Clinical Trial. JAMA Surg (2016) 0.75